Cargando…

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison

T-cell Acute Lymphoblastic Leukemia (T-ALL) is an aggressive subtype of leukemia for which important progress in treatment efficiency have been made in the past decades to reach a cure rate of 75%–80% nowadays. It is nevertheless mandatory to find new targets and active molecules for innovative ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonnet, Raphaël, Nebout, Marielle, Brousse, Carine, Reinier, Frédéric, Imbert, Véronique, Rohrlich, Pierre Simon, Peyron, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680901/ https://www.ncbi.nlm.nih.gov/pubmed/33240808 http://dx.doi.org/10.3389/fonc.2020.557643

Ejemplares similares

Structure–function insights reveal the human ribosome as a cancer target for antibiotics
por: Myasnikov, Alexander G., et al.
Publicado: (2016)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia
por: Muselli, Fabien, et al.
Publicado: (2023)

Identification of potentially anti-COVID-19 active drugs using the connectivity MAP
por: Bonnet, Raphaël, et al.
Publicado: (2022)

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
por: Nehdi, Atef, et al.
Publicado: (2021)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021)

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
por: Cruz-Burgos, Marian, et al.
Publicado: (2021)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Should a Multigene Signature be Used in all Luminal Early Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2019)

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
por: Li, Ling, et al.
Publicado: (2020)

Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
por: Xu, Jiabin, et al.
Publicado: (2020)

Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
por: Kori, Medi, et al.
Publicado: (2023)

Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018)

A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)

Natural killer cells and dendritic epidermal γδ T cells orchestrate type 1 conventional DC spatiotemporal repositioning toward CD8(+) T cells
por: Ghilas, Sonia, et al.
Publicado: (2021)

From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
por: Namba, Satoko, et al.
Publicado: (2022)

Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2020)

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
por: Oh, Jisun, et al.
Publicado: (2022)

lncRNA pair as candidate diagnostic signature for colorectal cancer based on the within-sample relative expression levels
por: Wang, Ouxi, et al.
Publicado: (2022)

Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer
por: Shigemizu, Daichi, et al.
Publicado: (2012)

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
por: Yu, Katharine, et al.
Publicado: (2023)

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer
por: Chen, Hsiao-Rong, et al.
Publicado: (2016)

Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models
por: Muselli, Fabien, et al.
Publicado: (2021)

Peptidoglycan Recognition Peptide 2 Aggravates Weight Loss in a Murine Model of Chemotherapy-Induced Gastrointestinal Toxicity
por: Bech, Ann-Sophie, et al.
Publicado: (2021)

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
por: Liu, Bo, et al.
Publicado: (2022)

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
por: Griessinger, Emmanuel, et al.
Publicado: (2023)

Drug repositioning for idiopathic epilepsy using gene expression signature data
por: Kumar, Pawan, et al.
Publicado: (2022)

Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2014)

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
por: Yuan, Meng, et al.
Publicado: (2022)

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
por: Merlini, Alessandra, et al.
Publicado: (2022)

Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kgl114f321orgomnh3uhkh1ibg